PCC Rokita SA

WSE:PCR Voorraadrapport

Marktkapitalisatie: zł1.6b

PCC Rokita Beheer

Beheer criteriumcontroles 3/4

De CEO PCC Rokita is Wieslaw Klimkowski, benoemd in Jan2005, heeft een ambtstermijn van 19.83 jaar. De totale jaarlijkse vergoeding van { bedraagt PLN 20.28M, bestaande uit 14.1% salaris en 85.9% bonussen, inclusief aandelen en opties van het bedrijf. bezit rechtstreeks 0.5% van de aandelen van het bedrijf, ter waarde PLN 7.99M. De gemiddelde ambtstermijn van het managementteam en de raad van bestuur bedraagt respectievelijk 14.8 jaar en 8.8 jaar.

Belangrijke informatie

Wieslaw Klimkowski

Algemeen directeur

zł20.3m

Totale compensatie

Percentage CEO-salaris14.1%
Dienstverband CEO19.8yrs
Eigendom CEO0.5%
Management gemiddelde ambtstermijn14.8yrs
Gemiddelde ambtstermijn bestuur8.8yrs

Recente managementupdates

Recent updates

Is There An Opportunity With PCC Rokita SA's (WSE:PCR) 36% Undervaluation?

May 30
Is There An Opportunity With PCC Rokita SA's (WSE:PCR) 36% Undervaluation?

Is PCC Rokita (WSE:PCR) Using Too Much Debt?

Aug 24
Is PCC Rokita (WSE:PCR) Using Too Much Debt?

PCC Rokita's (WSE:PCR) Shareholders Will Receive A Bigger Dividend Than Last Year

Apr 29
PCC Rokita's (WSE:PCR) Shareholders Will Receive A Bigger Dividend Than Last Year

Is PCC Rokita (WSE:PCR) A Risky Investment?

Jan 18
Is PCC Rokita (WSE:PCR) A Risky Investment?

PCC Rokita (WSE:PCR) Is Increasing Its Dividend To zł13.23

Apr 16
PCC Rokita (WSE:PCR) Is Increasing Its Dividend To zł13.23

Why We Like The Returns At PCC Rokita (WSE:PCR)

Mar 19
Why We Like The Returns At PCC Rokita (WSE:PCR)

What Is PCC Rokita SA's (WSE:PCR) Share Price Doing?

Jan 25
What Is PCC Rokita SA's (WSE:PCR) Share Price Doing?

We Like These Underlying Return On Capital Trends At PCC Rokita (WSE:PCR)

Sep 01
We Like These Underlying Return On Capital Trends At PCC Rokita (WSE:PCR)

Why PCC Rokita SA (WSE:PCR) Could Be Worth Watching

Jun 14
Why PCC Rokita SA (WSE:PCR) Could Be Worth Watching

Are PCC Rokita SA (WSE:PCR) Investors Paying Above The Intrinsic Value?

May 18
Are PCC Rokita SA (WSE:PCR) Investors Paying Above The Intrinsic Value?

Returns On Capital At PCC Rokita (WSE:PCR) Have Hit The Brakes

Apr 13
Returns On Capital At PCC Rokita (WSE:PCR) Have Hit The Brakes

Why PCC Rokita's (WSE:PCR) Earnings Are Better Than They Seem

Mar 23
Why PCC Rokita's (WSE:PCR) Earnings Are Better Than They Seem

PCC Rokita SA's (WSE:PCR) Has Been On A Rise But Financial Prospects Look Weak: Is The Stock Overpriced?

Mar 09
PCC Rokita SA's (WSE:PCR) Has Been On A Rise But Financial Prospects Look Weak: Is The Stock Overpriced?

Looking For Steady Income For Your Dividend Portfolio? Is PCC Rokita SA (WSE:PCR) A Good Fit?

Feb 19
Looking For Steady Income For Your Dividend Portfolio? Is PCC Rokita SA (WSE:PCR) A Good Fit?

What Does PCC Rokita SA's (WSE:PCR) Share Price Indicate?

Feb 04
What Does PCC Rokita SA's (WSE:PCR) Share Price Indicate?

Is PCC Rokita (WSE:PCR) Using Too Much Debt?

Jan 15
Is PCC Rokita (WSE:PCR) Using Too Much Debt?

Should We Be Excited About The Trends Of Returns At PCC Rokita (WSE:PCR)?

Dec 30
Should We Be Excited About The Trends Of Returns At PCC Rokita (WSE:PCR)?

Reflecting on PCC Rokita's (WSE:PCR) Share Price Returns Over The Last Three Years

Dec 17
Reflecting on PCC Rokita's (WSE:PCR) Share Price Returns Over The Last Three Years

PCC Rokita SA's (WSE:PCR) Stock is Soaring But Financials Seem Inconsistent: Will The Uptrend Continue?

Dec 03
PCC Rokita SA's (WSE:PCR) Stock is Soaring But Financials Seem Inconsistent: Will The Uptrend Continue?

Are Dividend Investors Getting More Than They Bargained For With PCC Rokita SA's (WSE:PCR) Dividend?

Nov 20
Are Dividend Investors Getting More Than They Bargained For With PCC Rokita SA's (WSE:PCR) Dividend?

Analyse CEO-vergoeding

Hoe is Wieslaw Klimkowski's beloning veranderd ten opzichte van PCC Rokita's winst?
DatumTotale vergoedingSalarisBedrijfswinsten
Jun 30 2024n/an/a

zł158m

Mar 31 2024n/an/a

zł144m

Dec 31 2023zł20mzł3m

zł268m

Sep 30 2023n/an/a

zł473m

Jun 30 2023n/an/a

zł589m

Mar 31 2023n/an/a

zł692m

Dec 31 2022zł43mzł2m

zł675m

Sep 30 2022n/an/a

zł569m

Jun 30 2022n/an/a

zł499m

Mar 31 2022n/an/a

zł472m

Dec 31 2021zł10mzł826k

zł417m

Sep 30 2021n/an/a

zł294m

Jun 30 2021n/an/a

zł247m

Mar 31 2021n/an/a

zł171m

Dec 31 2020zł5mzł573k

zł117m

Sep 30 2020n/an/a

zł73m

Jun 30 2020n/an/a

zł82m

Mar 31 2020n/an/a

zł72m

Dec 31 2019zł4mzł563k

zł93m

Sep 30 2019n/an/a

zł145m

Jun 30 2019n/an/a

zł160m

Mar 31 2019n/an/a

zł201m

Dec 31 2018zł4mzł838k

zł227m

Sep 30 2018n/an/a

zł243m

Jun 30 2018n/an/a

zł215m

Mar 31 2018n/an/a

zł213m

Dec 31 2017zł2mzł314k

zł182m

Compensatie versus markt: De totale vergoeding ($USD 5.06M ) Wieslaw } ligt boven het gemiddelde voor bedrijven van vergelijkbare omvang in de Polish markt ($USD 659.44K ).

Compensatie versus inkomsten: De vergoeding van Wieslaw is het afgelopen jaar in lijn geweest met de bedrijfsprestaties.

CEO

Wieslaw Klimkowski

19.8yrs

Tenure

zł20,278,000

Compensatie

Mr. Wieslaw Klimkowski serves as the President of the Management Boards at Rokita S.A. and Silesia-Kalk Sp. z o.o. Mr. Klimkowski served as Director of Investor Supervision & Group Development of PCC Rokit...

Leiderschapsteam

NaamPositieTenureCompensatieEigendom
Wieslaw Klimkowski
President of the Management & General Director19.8yrszł20.28m0.50%
PLN 8.0m
Rafal Zdon
Vice President of the Management Board & Financial Director14.8yrszł16.59m0.34%
PLN 5.3m
Robert Pabich
Secretary of the Supervisory Board & Independent Member of Supervisory Board10yrszł207.00kgeen gegevens
Beata Dobecka
Chief Accountantno datageen gegevensgeen gegevens

14.8yrs

Gemiddelde duur

Ervaren management: Het managementteam van PCR is doorgewinterd en ervaren (gemiddelde ambtstermijn van 14.8 jaar).

Bestuursleden

NaamPositieTenureCompensatieEigendom
Robert Pabich
Secretary of the Supervisory Board & Independent Member of Supervisory Board8.7yrszł207.00kgeen gegevens
Alfred Pelzer
Chairman of the Supervisory Board12.5yrsgeen gegevensgeen gegevens
Waldemar Preussner
Deputy Chairman of Supervisory Board12.5yrsgeen gegevensgeen gegevens
Mariusz Dopierala
Member of Supervisory Board8.8yrszł204.00kgeen gegevens
Arkadiusz Szymanek
Independent Member of Supervisory Board7.8yrszł307.00kgeen gegevens

8.8yrs

Gemiddelde duur

Ervaren bestuur: De raad van bestuur van PCR wordt beschouwd als ervaren (gemiddelde ambtstermijn 8.8 jaar).